Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Year-over-year net income growth rate
3Y CAGR
-49.0%/yr
Quarterly compound
Percentile
P56
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.67% |
| Q3 2025 | -45.70% |
| Q2 2025 | -4.22% |
| Q1 2025 | -66.08% |
| Q4 2024 | -58.24% |
| Q3 2024 | -10.78% |
| Q2 2024 | 5.90% |
| Q1 2024 | -17.78% |
| Q4 2023 | -63.57% |
| Q3 2023 | -78.24% |
| Q2 2023 | 21.36% |
| Q1 2023 | 44.81% |
| Q4 2022 | 12.61% |
| Q3 2022 | -1.94% |
| Q2 2022 | -5.13% |
| Q1 2022 | 15.23% |
| Q4 2021 | 15.48% |
| Q3 2021 | -121.24% |
| Q2 2021 | 92.77% |
| Q1 2021 | -739.23% |
| Q4 2020 | -27.44% |
| Q3 2020 | -3.44% |
| Q2 2020 | 19.14% |
| Q1 2020 | 4.91% |
| Q4 2019 | -25.54% |
| Q3 2019 | -26.24% |
| Q2 2019 | -8.91% |
| Q1 2019 | 27.51% |
| Q4 2018 | -45.26% |
| Q3 2018 | 17.75% |
| Q2 2018 | -56.55% |
| Q1 2018 | 11.22% |
| Q4 2017 | -8.88% |
| Q3 2017 | 58.67% |
| Q2 2017 | 8.84% |
| Q1 2017 | 88.95% |
| Q4 2016 | -593.72% |
| Q3 2016 | 7.92% |
| Q2 2016 | 13.44% |
| Q1 2016 | -19.30% |